Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Scribe Therapeutics, Inc. is a clinical-stage biotechnology company engineering purpose-built in vivo CRISPR technologies designed to extend healthy lifespan through disease prevention and durable therapeutic intervention. It focuses on cardiovascular and metabolic (CVM) diseases with initial programs to address the key drivers of atherosclerotic cardiovascular disease (ASCVD). The Company's lead product candidate, STX-1150, is an epigenetic silencing therapy that is based on its ELXR technology and is designed to durably lower LDL-C for years to decades by repressing the expression of PCSK9, a genetically and clinically validated target. STX-1150 is designed to achieve long-lasting therapeutic benefit without permanently altering the underlying DNA sequence. Its pipeline also includes STX-1200 and STX-1400, target two additional lipid drivers of ASCVD, elevated Lp(a) and severely high triglycerides, by editing the LPA and APOC3 genes, respectively.
Find out what a historical investment in Scribe Therapeutics Inc. would be worth today using our SCTX stock calculator.
Buying SCTX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Scribe Therapeutics Inc. in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in SCTX
What is the ticker symbol of Scribe Therapeutics Inc.?
The ticker symbol for Scribe Therapeutics Inc. is SCTX.
How much is one share of SCTX?
One share of SCTX is valued at $13.22 as of 20 November 2026.
What is the market capitalisation of Scribe Therapeutics Inc. SCTX?
As of 20 November 2026 Scribe Therapeutics Inc. has a market cap of $266.07M.
What is the 52-week high for Scribe Therapeutics Inc. stock?
The Scribe Therapeutics Inc. 52-week high stock price is $39.60.
What is the 52-week low for Scribe Therapeutics Inc. stock?
The Scribe Therapeutics Inc. 52-week low stock price is $12.58.
Can I buy SCTX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy SCTX shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in SCTX on Stake
Buy SCTX from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of SCTX from only US$10 with fractional shares